Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
DDDD.L Share News (DDDD)
DDDD Share
Price
DDDD Share
News
DDDD Share
Chat
DDDD Share
Trades
DDDD
Live RNS
DDDD Share
Charts
DDDD Broker
Ratings
DDDD Directors
Deals
DDDD Financial
Diary
DDDD
Fundamentals
DDDD Short
Positions
DDDD
Media
DDDD Company
Research
DDDD Company
Timeline
- There is currently no data for DDDD
4D Pharma Appoints Two Non-Executives From Xencor And Celgene
LONDON (Alliance News) - 4D Pharma PLC said Tuesday it has appointed two new independent non-executive directors, one a previous chief business officer at Xencor Inc and the other a former senior vice president at Celgene Corp.
Both will join with immediate effect.
Ed Baracchini led strategic alliances and licencing at Xencor. Prior to joining Xencor, Baracchini was senior vice president of business development at Metabasis Therapeutics Inc.
Axel Glasmacher served various roles at Celgene over his ten-year stay with the company.
Shares in 4D Pharma were up 1.8% at 119.32 pence on Tuesday.
Latest DDDD News
- IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM
15 Feb 2023 - TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil
3 Feb 2023 - UK shareholder meetings calendar - next 7 days
9 Jan 2023 - 4D Pharma seeks approval for equity fundraise to lift suspension
30 Dec 2022 - 4D Pharma says trial results show Blautix eases IBS symptoms
16 Nov 2022 - IN BRIEF: 4D Pharma publishes pre-clinical research for autism
24 Aug 2022 - TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim
5 Aug 2022 - TRADING UPDATES: Capital wins contracts; 4D pharma pauses enrolment
1 Jul 2022
Related News
IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM
4D Pharma PLC - Leeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administration in June ...
TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
DDDD.L News
IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM
4D Pharma PLC - Leeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administration in June ...
TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
4D Pharma seeks approval for equity fundraise to lift suspension
(Alliance News) - 4D Pharma PLC on Friday said it was seeking shareholder approval for a USD15.0 million cash raise, as it works to lift its suspensio...
4D Pharma says trial results show Blautix eases IBS symptoms
(Alliance News) - 4D Pharma PLC said on Wednesday that its Blautix phase 2 clinical trial results showed the treatment had a positive effect on suffer...
IN BRIEF: 4D Pharma publishes pre-clinical research for autism
4D Pharma PLC - Leeds, England-based pharmaceutical company - Releases its publication of pre-clinical research on mice regarding live biotherapeutic ...
TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by A...
TRADING UPDATES: Capital wins contracts; 4D pharma pauses enrolment
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Friday and not separately reported by Alli...
Follow the stocks
